Cargando…

Polio by the Numbers—A Global Perspective( )

BACKGROUND: Investments in national immunization programs and the Global Polio Eradication Initiative (GPEI) have resulted in substantial reductions in paralytic polio worldwide. However, cases prevented because of investments in immunization programs and GPEI remain incompletely characterized. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Badizadegan, Kamran, Kalkowska, Dominika A, Thompson, Kimberly M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556648/
https://www.ncbi.nlm.nih.gov/pubmed/35415741
http://dx.doi.org/10.1093/infdis/jiac130
_version_ 1784807108842094592
author Badizadegan, Kamran
Kalkowska, Dominika A
Thompson, Kimberly M
author_facet Badizadegan, Kamran
Kalkowska, Dominika A
Thompson, Kimberly M
author_sort Badizadegan, Kamran
collection PubMed
description BACKGROUND: Investments in national immunization programs and the Global Polio Eradication Initiative (GPEI) have resulted in substantial reductions in paralytic polio worldwide. However, cases prevented because of investments in immunization programs and GPEI remain incompletely characterized. METHODS: Using a global model that integrates polio transmission, immunity, and vaccine dynamics, we provide estimates of polio incidence and numbers of paralytic cases prevented. We compare the results with reported cases and estimates historically published by the World Health Organization. RESULTS: We estimate that the existence and use of polio vaccines prevented 5 million cases of paralytic polio for 1960–1987 and 24 million cases worldwide for 1988–2021 compared to a counterfactual world with no polio vaccines. Since the 1988 resolution to eradicate polio, our estimates suggest GPEI prevented 2.5–6 million cases of paralytic polio compared to counterfactual worlds without GPEI that assume different levels of intensity of polio vaccine use in routine immunization programs. CONCLUSIONS: Analysis of historical cases provides important context for understanding and communicating the benefits of investments made in polio eradication. Prospective studies will need to explore the expected benefits of future investments, the outcomes of which will depend on whether and when polio is globally eradicated.
format Online
Article
Text
id pubmed-9556648
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95566482022-10-19 Polio by the Numbers—A Global Perspective( ) Badizadegan, Kamran Kalkowska, Dominika A Thompson, Kimberly M J Infect Dis Major Article BACKGROUND: Investments in national immunization programs and the Global Polio Eradication Initiative (GPEI) have resulted in substantial reductions in paralytic polio worldwide. However, cases prevented because of investments in immunization programs and GPEI remain incompletely characterized. METHODS: Using a global model that integrates polio transmission, immunity, and vaccine dynamics, we provide estimates of polio incidence and numbers of paralytic cases prevented. We compare the results with reported cases and estimates historically published by the World Health Organization. RESULTS: We estimate that the existence and use of polio vaccines prevented 5 million cases of paralytic polio for 1960–1987 and 24 million cases worldwide for 1988–2021 compared to a counterfactual world with no polio vaccines. Since the 1988 resolution to eradicate polio, our estimates suggest GPEI prevented 2.5–6 million cases of paralytic polio compared to counterfactual worlds without GPEI that assume different levels of intensity of polio vaccine use in routine immunization programs. CONCLUSIONS: Analysis of historical cases provides important context for understanding and communicating the benefits of investments made in polio eradication. Prospective studies will need to explore the expected benefits of future investments, the outcomes of which will depend on whether and when polio is globally eradicated. Oxford University Press 2022-04-13 /pmc/articles/PMC9556648/ /pubmed/35415741 http://dx.doi.org/10.1093/infdis/jiac130 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Major Article
Badizadegan, Kamran
Kalkowska, Dominika A
Thompson, Kimberly M
Polio by the Numbers—A Global Perspective( )
title Polio by the Numbers—A Global Perspective( )
title_full Polio by the Numbers—A Global Perspective( )
title_fullStr Polio by the Numbers—A Global Perspective( )
title_full_unstemmed Polio by the Numbers—A Global Perspective( )
title_short Polio by the Numbers—A Global Perspective( )
title_sort polio by the numbers—a global perspective( )
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556648/
https://www.ncbi.nlm.nih.gov/pubmed/35415741
http://dx.doi.org/10.1093/infdis/jiac130
work_keys_str_mv AT badizadegankamran poliobythenumbersaglobalperspective
AT kalkowskadominikaa poliobythenumbersaglobalperspective
AT thompsonkimberlym poliobythenumbersaglobalperspective